SECURITIES PURCHASE AGREEMENT
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of April 30, 2021, by and between RESPIRERX PHARMACEUTICALS INC., a Delaware corporation, with headquarters located at 126 Valley Road, Suite C, Glen Rock, NJ 07452 (the “Company”), and LABRYS FUND, LP, a Delaware limited partnership, with its address at 48 Parker Road, Wellesley, MA 02482 (the “Buyer”).
ADDITIONAL COVENANTS, AGREEMENTS AND ACKNOWLEDGEMENTS.
LABRYS FUND, LP48 Parker RoadWellesley, MA 02482e-mail: admin@equiluxgroup.com 4.3 Amendments.
RESPIRERX PHARMACEUTICALS INC.  EXHIBIT A — NOTICE OF CONVERSION The undersigned hereby elects to convert $ principal amount of the Note (defined below) into that number of shares of Common Stock to be issued pursuant to the conversion of the Note (“Common Stock”) as set forth below, of RESPIRERX PHARMACEUTICALS INC., a Delaware corporation (the “Borrower”), according to the conditions of the promissory note of the Borrower dated as of April 30, 2021 (the “Note”), as of the date written below.
 EXHIBIT B FORM OF PIGGY-BACK REGISTRATION RIGHTS AGREEMENT [attached hereto] PIGGY-BACK REGISTRATION RIGHTS AGREEMENT THIS PIGGY-BACK REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of April 30, 2021, is made by and between RespireRx Pharmaceuticals Inc., a Delaware corporation (the “Company”), and Labrys Fund, LP, a Delaware limited partnership (the “Holder”).
